(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 13.76%42.1M | 15.84%120.21M | -19.01%37.01M | 4.69%103.77M | 8.09%45.7M | 22.37%99.12M | 16.95%42.27M | -13.04%81M | -10.48%36.15M | -19.08%93.15M |
Operating income | 13.76%42.1M | 15.84%120.21M | -19.01%37.01M | 4.69%103.77M | 8.09%45.7M | 22.37%99.12M | 16.95%42.27M | -13.04%81M | -10.48%36.15M | -19.08%93.15M |
Cost of sales | -22.22%-24.25M | -16.77%-65.06M | 9.22%-19.84M | -25.74%-55.72M | -17.36%-21.86M | -18.44%-44.31M | -20.58%-18.63M | 6.65%-37.41M | 4.56%-15.45M | 10.99%-40.07M |
Operating expenses | -22.22%-24.25M | -16.77%-65.06M | 9.22%-19.84M | -25.74%-55.72M | -17.36%-21.86M | -18.44%-44.31M | -20.58%-18.63M | 6.65%-37.41M | 4.56%-15.45M | 10.99%-40.07M |
Gross profit | 3.99%17.85M | 14.76%55.15M | -27.99%17.17M | -12.33%48.05M | 0.79%23.84M | 25.74%54.81M | 14.24%23.65M | -17.87%43.59M | -14.44%20.7M | -24.27%53.07M |
Selling expenses | -110.98%-12.7M | -105.10%-29.17M | 3.66%-6.02M | 5.61%-14.22M | -29.33%-6.25M | -59.71%-15.07M | -34.18%-4.83M | -5.61%-9.44M | 7.90%-3.6M | -3.86%-8.93M |
Administrative expenses | -41.50%-27.64M | -78.13%-43.3M | -90.23%-19.54M | -44.51%-24.31M | -63.86%-10.27M | -10.73%-16.82M | 4.34%-6.27M | 2.14%-15.19M | 5.54%-6.55M | 21.97%-15.53M |
Research and development expenses | -7.44%-20.62M | -6.37%-38.92M | -34.15%-19.19M | -52.63%-36.59M | -19.34%-14.31M | -10.58%-23.97M | -6.79%-11.99M | 4.25%-21.68M | 2.48%-11.23M | -21.01%-22.64M |
Impairment and provision | -76.36%52K | -135.39%-572K | 136.56%220K | 63.01%-243K | 111.36%93K | -1,094.55%-657K | -31.25%44K | 93.81%-55K | 60.00%64K | -535.00%-889K |
-Other impairment is provision | -76.36%52K | -135.39%-572K | 136.56%220K | 63.01%-243K | 111.36%93K | -1,094.55%-657K | -31.25%44K | 93.81%-55K | 60.00%64K | -535.00%-889K |
Special items of operating profit | -32.97%4.27M | -27.03%9.24M | 77.16%6.37M | 144.94%12.66M | 36.23%3.6M | 23.81%5.17M | 23.26%2.64M | -60.69%4.18M | -62.51%2.14M | 14.92%10.62M |
Operating profit | -84.78%-38.79M | -224.69%-47.59M | -536.31%-20.99M | -523.83%-14.66M | -201.66%-3.3M | 146.65%3.46M | 112.37%3.25M | -91.07%1.4M | -79.87%1.53M | -50.89%15.7M |
Financing cost | -39.49%-219K | -2.80%-367K | 16.49%-157K | 24.68%-357K | -9.30%-188K | -62.89%-474K | ---172K | -94.00%-291K | ---- | ---150K |
Earning before tax | -84.45%-39.01M | -219.42%-47.95M | -506.51%-21.15M | -603.12%-15.01M | -213.47%-3.49M | 168.59%2.98M | 101.11%3.07M | -92.86%1.11M | -79.87%1.53M | -51.36%15.55M |
Tax | -113.56%-24K | -27.82%641K | -52.42%177K | 78.67%888K | 776.36%372K | 4,241.67%497K | -114.75%-55K | 99.56%-12K | 127.94%373K | 32.83%-2.74M |
After-tax profit from continuing operations | -86.12%-39.03M | -234.96%-47.31M | -573.26%-20.97M | -505.77%-14.13M | -203.21%-3.12M | 216.74%3.48M | 58.76%3.02M | -91.42%1.1M | -69.61%1.9M | -54.07%12.81M |
Earning after tax | -86.12%-39.03M | -234.96%-47.31M | -573.26%-20.97M | -505.77%-14.13M | -203.21%-3.12M | 216.74%3.48M | 58.76%3.02M | -91.42%1.1M | -69.61%1.9M | -54.07%12.81M |
Minority profit | -524.35%-488K | 92.81%-158K | 133.24%115K | -1,255.56%-2.2M | -484.44%-346K | -3,140.00%-162K | 127.86%90K | ---5K | ---323K | ---- |
Profit attributable to shareholders | -82.79%-38.55M | -295.30%-47.16M | -661.54%-21.09M | -427.45%-11.93M | -194.57%-2.77M | 229.98%3.64M | 31.65%2.93M | -91.38%1.1M | -64.44%2.22M | -54.07%12.81M |
Basic earnings per share | -82.67%-0.0506 | -281.08%-0.0705 | -422.64%-0.0277 | -353.42%-0.0185 | -191.38%-0.0053 | 231.82%0.0073 | 31.82%0.0058 | -91.27%0.0022 | -64.23%0.0044 | -55.08%0.0252 |
Diluted earnings per share | -82.67%-0.0506 | -281.08%-0.0705 | -422.64%-0.0277 | -353.42%-0.0185 | -191.38%-0.0053 | 0.0073 | 31.82%0.0058 | -64.23%0.0044 | -55.08%0.0252 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data